Table 3.
β (SE)a | p-value | |
---|---|---|
Lipophilic statins | ||
LDL-C | 0.011 (0.008) | 0.148 |
Lipophilic statins | −9.841 (5.929) | 0.097 |
LDL-C * lipophilic statins | 0.072 (0.045) | 0.108 |
TG/HDL-C raio | −0.398 (0.190) | 0.037 |
Lipophilic statins | 2.792 (2.494) | 0.263 |
TG/HDL-C raio * lipophilic statins | −3.161 (2.170) | 0.145 |
Statins (lipophilic and hydrophilic statins) | ||
LDL-C | 0.010 (0.008) | 0.246 |
Statins | −3.835 (2.568) | 0.135 |
LDL-C * statins | 0.033 (0.021) | 0.104 |
TG/HDL-C ratio | −0.338 (0.193) | 0.079 |
Statins | 1.288 (1.099) | 0.241 |
TG/HDL-C raio * statins | −0.830 (0.688) | 0.228 |
Lipid lowering drugs (statins and non statins) | ||
LDL-C | 0.010 (0.008) | 0.232 |
Lipid lowering drugs | −3.415 (2.493) | 0.171 |
LDL-C * lipid lowering drugs | 0.030 (0.020) | 0.130 |
TG/HDL-C ratio | −0.331 (0.194) | 0.089 |
Lipid lowering drugs | 1.257 (1.041) | 0.228 |
TG/HDL-C ratio * lipid lowering drugs | −0.793 (0.651) | 0.224 |
HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein cholesterol, TG = triglyceride
Adjusted for age, gender, years of education, use of lipid-lowering drugs, history of stroke and heart diseases, hypertension, diabetes, and current smoking and alcohol drinking status